Blood thinners may protect against COVID-19 complications
A new study has found that administering heparin-based blood thinners to patients with COVID-19 in the first 24 hours of hospital admission reduced the risk […]
Home »
Results from the ACTT-2 trial reveal that baricitinib combined with remdesivir reduced the recovery time of hospitalized COVID-19 patients from 8 to 7 days. The […] A study reveals the disproportionate economic impact of COVID-19 shutdowns on low-income Black households. In the United States, COVID-19 has struck communities of color with […] A new study suggests that face masks have a negligible negative effect on the levels of carbon dioxide and oxygen that a person breathes. The […] An observational study found that people with COVID-19 who received these drugs early fared better than those who received them after they became critically ill. […] Doctors on the frontline of the COVID-19 outbreak in New York City have published the first comprehensive review of the disease’s widespread effects on organ […] A recent large-scale study concludes that both type 1 and type 2 diabetes are associated with an increased risk of COVID-19-related in-hospital death. It finds […] A recent study suggesting that the novel coronavirus accumulates in the testes has gained significant media attention. In this article, we see how experts have […] A new model has predicted that demand for beds in intensive care units (ICUs) will outstrip supply in two regions of the United Kingdom by […]
Remdesivir and baricitinib shortened recovery time from COVID-19
Low-income Black people in US hit hardest by shutdowns
Face masks have negligible negative effect on CO2 and O2 levels
Severe COVID-19: Interleukin-6 inhibitors may be most effective
COVID-19: Doctors round up evidence of damage outside the lungs
Diabetes and COVID-19 in-hospital mortality rates
COVID-19: Are the testes really a coronavirus reservoir?
COVID-19 may overwhelm intensive care units in UK within weeks